Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug concentration and degradation profiles of postoperative steroid and antibiotic eye drops in human aqueous humor
2022-003825-24Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, single-arm trial of HiDex, dexamethasone, gentamicin, loteprednol etabonate and prednisolone in senile cataract (ARC), Postoperative ocular inflammation and well-being, sponsored by Medical University of Vienna. Primary endpoints: Active drug concentration in the aqueous humor and Drug degradation profile in aqueous humor. Started Apr 2023; status: active.
02
Drugs
HiDexdexamethasonegentamicinloteprednol etabonateprednisolone
03
Conditions
senile cataract (ARC)Postoperative ocular inflammationwell-being
Beyond the preview
Go deeper on 2022-003825-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003825-24.